Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, Olivier Bylicki, Catherine Dubos-Arvis, Bénédicte Comet, Marie Marcq, Jacques Le Treut, Jean-Bernard Auliac, Anne Madroszyk, Gislaine Fraboulet, Jacky Crequit, Pascal Thomas, Nicolas Paleiron & Isabelle Monnet. (2019) Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01). Cancer Management and Research 11, pages 10821-10826.
Read now
Read now
Paramjot, Nikhat Mansoor Khan, Himani Kapahi, Sahil Kumar, T. R. Bhardwaj, Saahil Arora & Neeraj Mishra. (2015) Role of polymer–drug conjugates in organ-specific delivery systems. Journal of Drug Targeting 23:5, pages 387-416.
Read now
Read now
Yujiong Wang, Guangcun Deng, Xiaoming Liu & William C Cho. (2013) Monoclonal antibodies in lung cancer. Expert Opinion on Biological Therapy 13:2, pages 209-226.
Read now
Read now
Jianjun Zhang, Kathryn A Gold & Edward Kim. (2012)
Sorafenib in non-small cell lung cancer. Expert Opinion on Investigational Drugs 21:9, pages 1417-1426.
Read now
Read now
Luis Leon, Sergio Vázquez, José Manuel Gracia, Joaquín Casal, Martín Lazaro, José Luis Firvida, Margarita Amenedo, Lucia Santome & Sonia Macia. (2012) First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients. Expert Opinion on Pharmacotherapy 13:10, pages 1389-1396.
Read now
Read now
Articles from other publishers (29)
Efe Taha BUCAK, Zuhal TUNÇBİLEK, Alakbar HUSEYNZADA, Mirjavid AGHAYEV, Ulviyya HASANOVA, Ayça TAŞ & Yavuz SİLİĞ. (2022) INVESTIGATION OF THE EFFECT OF COMPOUND B-47/2 CONTAINING AZOMETHINE GROUP ON ANGIOGENESIS. Cumhuriyet Medical Journal.
Crossref
Crossref
Mohammad Habeeb, Tasneem Abdul Kareem, Kolluru Lakshmi Deepthi, Vidyarani Sujitkumar Khot, You Huay Woon & Sarita Suryabhan Pawar. (2022) Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways. Journal of Drug Delivery Science and Technology 77, pages 103865.
Crossref
Crossref
Fakhara Sabir, Maimoona Qindeel, Mahira Zeeshan, Qurrat Ul Ain, Abbas Rahdar, Mahmood Barani, Edurne González & M. Ali Aboudzadeh. (2021) Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes 9:4, pages 621.
Crossref
Crossref
Matte Kasi Viswanadh, Vikas, Abhishek Jha, Sandeep Kumar Reddy Adena, Abhishesh Kumar Mehata, Vishnu Priya, Kaushik Neogi, Suruchi Poddar, Sanjeev Kumar Mahto & Madaswamy S Muthu. (2020)
Formulation and
in vivo
efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy
. Nanomedicine 15:24, pages 2345-2367.
Crossref
Crossref
Zhen Wang, Yisheng Zheng & Zhenjian Fang. (2018) The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion. Revista da Associação Médica Brasileira 64:3, pages 230-233.
Crossref
Crossref
Haleh Vosgha, Armin Ariana, Robert Anthony Smith & Alfred King-yin Lam. (2018) miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma. Endocrine-Related Cancer 25:3, pages 323-337.
Crossref
Crossref
Umar Farooq, Sadia Naz, Binte Zehra, Ajmal Khan, Syed Abid Ali, Ayaz Ahmed, Rizwana Sarwar, Syed Majid Bukhari, Abdur Rauf, Izhar Ahmad & Yahia Nasser Mabkhot. (2017) Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway. BMC Cancer 17:1.
Crossref
Crossref
Joel W. Neal & Heather A. Wakelee. (2017) Elusive Target of Angiogenesis in Small-Cell Lung Cancer. Journal of Clinical Oncology 35:12, pages 1269-1271.
Crossref
Crossref
Nan Qi, Fang Li, Xiaosong Li, Huanrong Kang, Hui Zhao & Nan Du. (2016) Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion. Medicine 95:47, pages e5392.
Crossref
Crossref
Lindsey Eldridge, Aigul Moldobaeva, Qiong Zhong, John Jenkins, Michael Snyder, Robert H. Brown, Wayne Mitzner & Elizabeth M. Wagner. (2016) Bronchial Artery Angiogenesis Drives Lung Tumor Growth. Cancer Research 76:20, pages 5962-5969.
Crossref
Crossref
Sara Carvalho, Esther G.C. Troost, Judith Bons, Paul Menheere, Philippe Lambin & Cary Oberije. (2016) Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation. Radiotherapy and Oncology 119:3, pages 487-494.
Crossref
Crossref
Zhenbo Tu. (2016) HMGB1: A POTENTIAL THERAPEUTIC TARGET FOR NON-SMALL CELL LUNG CANCER. Lettters in Health & Biological Sciences 1:2, pages 1-2.
Crossref
Crossref
Ali SalajeghehAli Salajegheh. 2016. Angiogenesis in Health, Disease and Malignancy. Angiogenesis in Health, Disease and Malignancy
363
374
.
Srijana Rai, Zaynab Nejadhamzeeigilani, Nicholas J. Gutowski & Jacqueline L. Whatmore. (2015) Loss of the endothelial glycocalyx is associated with increased E-selectin mediated adhesion of lung tumour cells to the brain microvascular endothelium. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Penny Nymark, Eeva Kettunen & Sakari Knuutila. 2015. Cancer Cytogenetics. Cancer Cytogenetics
361
372
.
Wei Zhao, Yan Wang, Ying Wang, Nan Gao, Zhifeng Han & Haixiang Yu. (2015) Potential anti-cancer effect of curcumin in human lung squamous cell carcinoma. Thoracic Cancer 6:4, pages 508-516.
Crossref
Crossref
Li Sun, Jie-Tao Ma, Shu-Ling Zhang, Hua-Wei Zou & Cheng-Bo Han. (2015) Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis. Medical Oncology 32:2.
Crossref
Crossref
Hui Xia, Yong-Fu Ma, Chang-Hai Yu, Ying-Jie Li, Jian Tang, Jing-Bo Li, Ying-Nan Zhao & Yang Liu. (2014) Aquaporin 3 knockdown suppresses tumour growth and angiogenesis in experimental non-small cell lung cancer. Experimental Physiology 99:7, pages 974-984.
Crossref
Crossref
HONG ZHANG, ZHIHONG LI & KAIZHONG WANG. (2014) Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo. Oncology Reports 31:4, pages 1954-1960.
Crossref
Crossref
Chun-Hua Ma, Rong Jiang, Jin-Duo Li, Bin Wang, Li-Wei Sun & Yuan Lv. (2014) Experimental Study on Residual Tumor Angiogenesis after Cryoablation. Asian Pacific Journal of Cancer Prevention 15:6, pages 2491-2494.
Crossref
Crossref
Neil R. Smith, Dawn Baker, Matthew Farren, Aurelien Pommier, Ruth Swann, Xin Wang, Sunita Mistry, Karen McDaid, Jane Kendrew, Chris Womack, Stephen R. Wedge & Simon T. Barry. (2013) Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy. Clinical Cancer Research 19:24, pages 6943-6956.
Crossref
Crossref
Kai Su, Lijun Huang, Wenhai Li, Xiaolong Yan, Xiaofei Li, Zhipei Zhang, Faguang Jin, Jie Lei, Guangzhen Ba, Boya Liu, Xiaoping Wang & Yunjie Wang. (2013) TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway. Journal of Surgical Research 185:1, pages 255-263.
Crossref
Crossref
Huilin Xu, Wei Ge, Pingpo Ming, Liang Liu, Dedong Cao, Changhu Li, Wei Luo & Jing Song. (2013) Jinshuixian in combination with radiotherapy suppresses the proliferation of A549 cells by inhibiting the expression of VEGF. The Chinese-German Journal of Clinical Oncology 12:9, pages 407-410.
Crossref
Crossref
RENPING ZHAO, LI SUN, SENSEN LIN, XIANSHU BAI, BOYANG YU, SHENGTAO YUAN & LUYONG ZHANG. (2013) The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity. Oncology Reports 29:4, pages 1379-1386.
Crossref
Crossref
Adilson Kleber Ferreira, Vanessa Morais Freitas, Débora Levy, Jorge Luiz Mária Ruiz, Sergio Paulo Bydlowski, Rose Eli Grassi Rici, Otaviano Mendonça R. Filho, Gilberto Orivaldo Chierice & Durvanei Augusto Maria. (2013) Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine. PLoS ONE 8:3, pages e57937.
Crossref
Crossref
Celine Mascaux, Simon Ekman, Christophe Dooms & Frances A. Shepherd. (2012) Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC). Current Respiratory Care Reports 2:1, pages 1-9.
Crossref
Crossref
Li He, Erying Zhang, Jingli Shi, Xiangyong Li, Keyuan Zhou, Qunzhou Zhang, Anh D. Le & Xudong Tang. (2013) (−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. Cancer Chemotherapy and Pharmacology 71:3, pages 713-725.
Crossref
Crossref
JIA-YING XU, QING-HUI MENG, YU CHONG, YANG JIAO, LIN ZHAO, ELIOT M. ROSEN & SAIJUN FAN. (2013) Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Molecular and Clinical Oncology 1:2, pages 331-336.
Crossref
Crossref
Xian-zhe Dong, Miao Zhang, Kun Wang, Ping Liu, Dai-hong Guo, Xiao-li Zheng & Xiao-yue Ge. (2013) Sanguinarine Inhibits Vascular Endothelial Growth Factor Release by Generation of Reactive Oxygen Species in MCF-7 Human Mammary Adenocarcinoma Cells. BioMed Research International 2013, pages 1-8.
Crossref
Crossref